نتایج جستجو برای: rosiglitazone

تعداد نتایج: 3061  

Journal: :Thrombosis Journal 2008
Olímpio Ribeiro França Neto Dalton Bertolim Precoma Alexandre Alessi Camila Prim Ruy Fernando Kuenzer Caetano da Silva Lucia de Noronha Liz Andréa Villela Baroncini

BACKGROUND The objective was to evaluate the effects of rosiglitazone on iliac arteries of hypercholesterolemic rabbits undergoing balloon catheter injury in the contralateral iliac arteries. METHODS White male rabbits were fed a hypercholesterolemic diet for 6 weeks and divided into two groups as follows: rosiglitazone group, 14 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) du...

2006
Bardia Askari Jenny E. Kanter Ashley M. Sherrid Deidre L. Golej Andrew T. Bender Joey Liu Willa A. Hsueh Joseph A. Beavo Rosalind A. Coleman Karin E. Bornfeldt

Rosiglitazone is an insulin-sensitizing agent that has recently been shown to exert beneficial effects on atherosclerosis. In addition to peroxisome proliferator-activated receptor (PPAR)γ, rosiglitazone can affect other targets, such as directly inhibiting recombinant long-chain acyl-CoA synthetase 4 (ACSL4) activity. Because it is unknown if ACSL4 is expressed in vascular cells involved in at...

Journal: :American journal of physiology. Gastrointestinal and liver physiology 2012
Xiuhua Sun Yunan Tang Xiaobing Tan Qiong Li Wei Zhong Xinguo Sun Wei Jia Craig J McClain Zhanxiang Zhou

The development of alcohol-induced fatty liver is associated with a reduction of white adipose tissue (WAT). Peroxisome proliferator-activated receptor (PPAR)-γ prominently distributes in the WAT and plays a crucial role in maintaining adiposity. The present study investigated the effects of PPAR-γ activation by rosiglitazone on lipid homeostasis at the adipose tissue-liver axis. Adult C57BL/6 ...

2017
You-Lei Li Xiao Li Tian-Tuan Jiang Jia-Min Fan Xue-Li Zheng Xin-E Shi Tai-Yong Yu Gui-Yan Chu Gong-She Yang

It is well-documented that CL316,243 (a β3 agonist) or rosiglitazone (a PPARγ agonist) can induce white adipocyte populations to brown-like adipocytes, thus increasing energy consumption and combating obesity. However, whether there is a combined effect remains unknown. In the present study, stromal vascular cells of inguinal white adipose tissue (iWAT-SVCs for short) from mice were cultured an...

2011
M. Sireesha R. S. Chandan

New, simple and sensitive spectrophotometric methods for the determination of rosiglitazone and pioglitazone have been developed. The method is based on the oxidation of 2, 4-dinitrophenyl hydrazine (2, 4DNP) and coupling of the oxidized product with rosiglitazone and pioglitazone to give intensely colored chromogen. Rosiglitazone and pioglitazone showed maximum absorbance at 421 nm and 480 nm ...

2011
Takako Araki Miroslava Varadinova Michael Goldman Zev Rosenwaks Leonid Poretsky Donna Seto-Young

We have previously reported that, in human granulosa cells, thiazolidinediones rosiglitazone and pioglitazone inhibit estrogen synthesis by interfering with androgen binding to aromatase, without an effect on aromatase mRNA or protein expression. In the current paper, we explore the effects of rosiglitazone and pioglitazone on the aromatase enzyme kinetic properties in human granulosa cells. Th...

Journal: :American journal of physiology. Endocrinology and metabolism 2009
Maria A Potenza Sara Gagliardi Leonarda De Benedictis Addolorata Zigrino Edy Tiravanti Giuseppe Colantuono Antonio Federici Loredana Lorusso Vincenzo Benagiano Michael J Quon Monica Montagnani

Oxidative stress contributes to cardiovascular complications of diabetes, in part, by reducing the bioavailability of nitric oxide (NO). We investigated the mechanisms whereby the insulin sensitizer rosiglitazone may ameliorate oxidative stress in the vasculature of spontaneously hypertensive rats (SHR). Nine-week-old SHR were treated by gavage for 7 wk with rosiglitazone (5 mg x kg(-1) x day(-...

2010
Richard L Morrow Greg Carney James M Wright Ken Bassett Jenny Sutherland Colin R Dormuth

BACKGROUND In May 2007 Nissen and Wolski reported the results of a meta-analysis showing an association between use of rosiglitazone and increased risk of myocardial infarction (N Engl J Med 2007;356(24):2457-2471). Rosiglitazone is an insulin-sensitizing agent used to control blood glucose levels in patients with type 2 diabetes. Subsequent analyses provided evidence that the meta-analysis led...

2013
Snehalata V. Gajbhiye Neelam A. Manjrekar

Objectives-To evaluate anti-inflammatory activity of rosiglitazone in the acute and chronic models of inflammation. Also to determine ulcerogenic potential on gastric mucosa in Wistar rats in comparison with diclofenac. Methodology-Anti-inflammatory effects of rosiglitazone in the dose of 1, 3 and 10 mg/kg b.wt., i.p were studied in acetic acid-induced peritoneal capillary permeability model in...

Journal: :Endocrinology 2014
Shumin Yang Ting Luo Huang Zhou Qiong Lv Lulu Liu Wenlong Zhang Rufei Gao Shumei Chen Wei Xia Mei Luo Qingfeng Cheng Qifu Li

Pigment epithelium-derived factor (PEDF) plays an important role in insulin resistance (IR). The study aims to investigate the effect of rosiglitazone, an insulin sensitizer, on PEDF production and release both in vivo and in vitro. Male SD rats were divided into normal control group, high-fat group, and rosiglitazone group. Hyperinsulinemic euglycemic clamp was performed to evaluate insulin se...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید